[Answered] ____Gagn-Briggs nine events of instruction is a macro theory of design. Indicate whether the ...

This topic contains a solution. Click here to go to the answer

Author Question: ____Gagn-Briggs nine events of instruction is a macro theory of design. Indicate whether the ... (Read 42 times)

olgavictoria

Hero Member
Posts: 528

on: Jul 7, 2018

____Gagn-Briggs nine events of instruction is a macro theory of design.

Indicate whether the statement is true or false

Question 2

The Wagner Act guarantees workers the right to ________ and join unions, to bargain collectively, and to act in concert to pursue their objectives.

A) strike
B) organize
C) protest
D) work
E) labor

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

strudel15

Sr. Member
Posts: 324

Reply #1 on: Jul 7, 2018

Answer to Question 1

False

Answer to Question 2

B

olgavictoria

Hero Member
Posts: 528

Reply #2 on: Jul 7, 2018

Thank you

strudel15

Sr. Member
Posts: 324

Reply #3 on: Jul 7, 2018

No problemo

« previous next »

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates’s recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

Cancer has been around as long as humankind, but only in the second half of the twentieth century did the number of cancer cases explode.

Did you know?

Vital signs (blood pressure, temperature, pulse rate, respiration rate) should be taken before any drug administration. Patients should be informed not to use tobacco or caffeine at least 30 minutes before their appointment.

Did you know?

According to the FDA, adverse drug events harmed or killed approximately 1,200,000 people in the United States in the year 2015.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.